Literature DB >> 16728587

Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue.

C L Wilson1, A H Sims, A Howell, C J Miller, R B Clarke.   

Abstract

Oestrogen (E) is essential for normal and cancer development in the breast, while anti-oestrogens have been shown to reduce the risk of the disease. However, little is known about the effect of E on gene expression in the normal human breast, particularly when the epithelium and stroma are intact. Previous expression profiles of the response to E have been performed on tumour cell lines, in the absence of stroma. We investigated gene expression in normal human breast tissue transplanted into 9-10-week-old female athymic nude (Balb/c nu/nu) mice. After 2 weeks, when epithelial proliferation is minimal, one-third of the mice were treated with 17beta-oestradiol (E2) to give human luteal-phase levels in the mouse, which we have previously shown to induce maximal epithelial cell proliferation. RNA was isolated from treated and untreated mice, labelled and hybridized to Affymetrix HG-U133A (human) GeneChips. Gene expression levels were generated using BioConductor implementations of the RMA and MAS5 algorithms. E2 treatment was found to represent the largest source of variation in gene expression and cross-species hybridization of mouse RNA from xenograft samples was demonstrated to be negligible. Known E2-responsive genes (such as TFF1 and AREG), and genes thought to be involved in breast cancer metastasis (including mammoglobin, KRT19 and AGR2), were upregulated in response to E treatment. Genes known to be co-expressed with E receptor alpha in breast cancer cell lines and tumours were both upregulated (XBP-1 and GREB1) and downregulated (RARRES1 and GATA3). In addition, genes that are normally expressed in the myoepithelium and extracellular matrix that maintain the tissue microenvironment were also differentially expressed. This suggests that the response to oestrogen in normal breast is highly dependent upon epithelial-stromal/myoepithelial interactions which maintain the tissue microenvironment during epithelial cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728587     DOI: 10.1677/erc.1.01165

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  36 in total

1.  Alterations of gene expression in the development of early hyperplastic precursors of breast cancer.

Authors:  Sangjun Lee; Dan Medina; Anna Tsimelzon; Syed K Mohsin; Sufeng Mao; Yun Wu; D Craig Allred
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

Review 2.  Estrogen and progesterone in normal mammary gland development and in cancer.

Authors:  John Stingl
Journal:  Horm Cancer       Date:  2010-12-16       Impact factor: 3.869

3.  Fetal arsenic exposure appears to facilitate endocrine disruption by postnatal diethylstilbestrol in neonatal mouse adrenal.

Authors:  Jie Liu; Limei Yu; Jean-Francois Coppin; Erik J Tokar; Bhalchandra A Diwan; Michael P Waalkes
Journal:  Chem Biol Interact       Date:  2009-08-07       Impact factor: 5.192

4.  Developmentally regulated SMAD2 and SMAD3 utilization directs activin signaling outcomes.

Authors:  Catherine Itman; Chris Small; Michael Griswold; Ankur K Nagaraja; Martin M Matzuk; Chester W Brown; David A Jans; Kate L Loveland
Journal:  Dev Dyn       Date:  2009-07       Impact factor: 3.780

5.  Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival.

Authors:  Vijaya Ramachandran; Thiruvengadam Arumugam; Huamin Wang; Craig D Logsdon
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

6.  Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemia.

Authors:  Amy L Samuels; Violet K Peeva; Rachael A Papa; Marin J Firth; Richard W Francis; Alex H Beesley; Richard B Lock; Ursula R Kees
Journal:  BMC Genomics       Date:  2010-04-21       Impact factor: 3.969

7.  Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer.

Authors:  Karen J Taylor; Andrew H Sims; Liang Liang; Dana Faratian; Morwenna Muir; Graeme Walker; Barbara Kuske; J Michael Dixon; David A Cameron; David J Harrison; Simon P Langdon
Journal:  Breast Cancer Res       Date:  2010-06-22       Impact factor: 6.466

8.  Profile of estrogen-responsive genes in an estrogen-specific mammary gland outgrowth model.

Authors:  Bonnie J Deroo; Sylvia C Hewitt; Jennifer B Collins; Sherry F Grissom; Katherine J Hamilton; Kenneth S Korach
Journal:  Mol Reprod Dev       Date:  2009-08       Impact factor: 2.609

9.  Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development.

Authors:  Laura Ciarloni; Sonia Mallepell; Cathrin Brisken
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-16       Impact factor: 11.205

10.  Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate.

Authors:  Howard Kendrick; Joseph L Regan; Fiona-Ann Magnay; Anita Grigoriadis; Costas Mitsopoulos; Marketa Zvelebil; Matthew J Smalley
Journal:  BMC Genomics       Date:  2008-12-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.